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Abstract
Background: Detection of bacterial nucleic acids in synovial fluid following total joint arthroplasty with suspected
infection can be difficult; among other technical challenges, inhibitors in the specimens require extensive sample
preparation and can diminish assay sensitivity even using polymerase chain reaction (PCR)-based methods. To
address this problem a simple protocol for prior use of multiple displacement amplification (MDA) as an adjunct to
PCR was established and tested on both purified S. aureus DNA as well as on clinical samples known to contain S.
aureus nucleic acids.
Findings: A single round of MDA on purified nucleic acids resulted in a > 300 thousand-fold increase in template
DNA on subsequent quantitative PCR (qPCR) analysis. MDA use on clinical samples resulted in at least a 100-fold
increase in sensitivity on subsequent qPCR and required no sample preparation other than a simple alkali/heat lysis
step. Mixed samples of S. aureus DNA with a 103 - 104-fold excess of human genomic DNA still allowed for MDA
amplification of the minor bacterial component to the threshold of detectability.
Conclusion: MDA is a promising technique that may serve to significantly enhance the sensitivity of molecular
assays in cases of suspected joint infection while simultaneously reducing the specimen handling required.
Background
Although molecular detection of pathogens in clinical
samples by PCR has been widely investigated, its relia-
bility is still questioned in some clinical scenarios. For
suspected infection following total joint arthroplasty,
PCR of 16S rDNA remains controversial as evidence for
pathogen presence and ongoing infection. Some reports
consider PCR-based techniques overly sensitive, poten-
tially indicating DNA even in the absence of clinical cri-
teria for infection [1]. Alternatively, it has been posited
that so-called “aseptic” loosening of prostheses may be
due to low-grade infection that remains difficult to
detect even with molecular techniques [2], and that
false-negatives may result from inefficient DNA extrac-
tion from target organisms (especially Gram-positives),
loss of DNA during sample processing, or the presence
of PCR inhibitors in clinical samples [3].
In synovial fluid the problem of PCR inhibitors is sig-
nificant, and virtually all studies evaluating orthopedic
joint infections with PCR techniques have first underta-
ken some means of isolating genomic DNA from the
clinical specimens [eg. [4-6]]. van der Heijden et al., for
example, employed a lysis buffer containing SDS and
proteinase K at 60C for 18 hours, followed by phenol
extraction and ethanol precipitation, but found that
additional purification with a QIAamp blood kit (Qia-
gen) was still necessary [7]. As a result of these various
concerns, PCR-based analysis of clinical joint aspirates is
not typically used as an aide to clinical decision-making
when confronted with a possibly infected joint
prosthesis.
A growing body of evidence supports the theory that
chronic prosthetic joint infections arise from bacterial
biofilms associated with the implants. Biofilm bacteria
are notoriously difficult to culture and highly resistant
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to conventional antibiotic therapy. Treatment of the
infected implant often requires explantation, inflicting
significant morbidity and entailing significant expense;
surgeons are understandably reluctant to undertake
such a course without good reason, but standard bacter-
ial culture of diagnostic aspirates is usually negative.
When culture results are positive, S. aureus is the most
frequently recovered organism in chronic joint implant
infections, although numerous unusual bacterial species
have also been implicated [8]. It would be an important
advance to establish a diagnostic protocol for such
infections that reliably improved sensitivity with a mini-
mum of specimen handling.
We have used multiple displacement amplification
(MDA) [9,10] to improve PCR detection of bacterial
DNA present in clinical samples using S. aureus as a
test organism. MDA amplifies all DNA content in a
sample including human and bacterial DNA [11,12]. It
facilitates subsequent PCR detection of bacteria by 1)
enriching DNA relative to PCR inhibitors (such as
hemoglobin and nucleases), 2) generating abundant
DNA template with less incidence of mutational error
than PCR amplification where low bacterial counts pro-
vide only suboptimal amounts of DNA, and 3) providing
a large source of DNA to carry out replicate PCR assays,
repeat assays to confirm results, interrogate an unlim-
ited number of genomic loci and any pathogen within a
mixed sample, and archive DNA for genomic sequen-
cing or other detailed studies. MDA is simple to employ
and requires no specialized equipment. Thus it may be
extremely useful in investigating complex clinical sam-
ples containing comparatively small quantities of target
organisms.
Methods
Quantitative PCR assay for S. aureus gene loci
In order to quantify the effect MDA can have, we first
established and validated a quantitative real-time PCR
assay for several single copy (not rDNA) gene loci in S.
aureus: lysS and proS. The primers and probes used are
listed in Table 1. 50 μl PCR reactions (containing vary-
ing concentrations of S. aureus genomic DNA) used
denaturation at 95C × 10 min; then 2-stage PCR at 95C
× 15 sec, and 60C × 1 min × 40 cycles total, with 0.5 μl
Platinum Taq polymerase (Invitrogen), 1× PCR buffer,
5 mM MgCl2, dNTPs at 1 mM, primers and Taqman
probe at 500 nM, and 1 μl of Rox reference dye. Assays
were performed in an ABI 7900HT Sequence Detection
System and critical cycle values were determined with
the manufacturer’s software.
Quantitation of purified S. aureus DNA after pre-
treatment with MDA
We first investigated the effect of MDA on purified
genomic DNA using the GenomiPhi MDA kit (GE-
Healthcare). Varying amounts of S. aureus DNA (iso-
lated as per [13] from reference strain Seattle 1945,
ATCC# 25923) from 0.01 ng to 100 ng were assayed
using the qPCR assays described above and a standard
curve was established. 0.01 ng of genomic S. aureus
DNA were also pre-incubated with 1 μl of the Genomi-
Phi enzyme for 16 hours at 30 C in 100 μl volume (as
per the manufacturer’s specifications). A corresponding
control reaction lacking only the GenomiPhi enzyme
itself was also carried out. 5 μl of the resulting material
(effectively a 1/20 dilution) were then assayed for DNA
content by qPCR as described above.
Assay for S. aureus DNA in clinical samples using MDA
MDA was next tested for S.aureus DNA in synovial
fluid from an elbow total joint arthroplasty patient
where infection was suspected but could not be con-
firmed by standard microbiology despite two years of
recurrent symptoms and multiple surgical and medical
interventions. We previously reported that bacteria in
biofilm configuration were observed in aspirate, tissue,
and cement samples from this patient by confocal
microscopy, and that PCR and reverse-transcriptase
PCR detected intact S. aureus (but not S. epidermidis)
DNA and mRNA respectively in purified nucleic acids
from the synovial fluid aspirate [14]. Two discrete sam-
ples were now subjected to qPCR analysis with and
without pre-treatment with MDA.
Elbow synovial fluid aspirate obtained with sterile
technique was placed either in RNAlater solution or in
a microfuge tube directly, then snap frozen in dry/ice
ethanol and preserved at -70C until further processing.
On thawing, 0.1 μl, 1 μl, or 10 μl of stored aspirate was
brought to a volume of 27 μl with phosphate buffered
saline (PBS), then lysed by addition of 1/10 vol (3 μl) of
400 mM KOH, 10 M EDTA with incubation at 65C × 3
minutes. The lysates were then neutralized by addition
of 3 μl of 800 mM Tris-HCl (~ pH 4), for a total
volume of 33 μl. As controls, the same volumes of
stored aspirate (0.1, 1 and 10 μl) were brought directly
to 33 μl with added PBS and were not lysed. Samples to
undergo MDA had 67 μl of MDA mix added, comprised
of 25 μl 4× MDA master mix, 41 μl water, and 1 μl of
Table 1 Primer and probe sequences used in qPCR assays
for lysS and proS
lysS primers 5′-GTCGTTTTGAAGCGCAACTT-3′
5′-CCTGTCGGAGGCATACCATA-3′
lysS probe 5′-GCGCAAGGTAATGATGAAGCGCA-3′ (6-FAM)
proS primers 5′-GGCATTAAGTGCTATCGGTGA-3′
5′-AAAGGTTGCACAGTAGAATGCTT-3′
proS probe 5′-GAAAAAGCAGAAGTCGTTTACGAACC-3′ (6-FAM)
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Phi 29 enzyme. Control samples that were not to
undergo MDA were prepared similarly, except with 42
μl of water and no GenomiPhi DNA polymerase. All
samples were incubated at 30C × 16 hours, then at 65C
× 3 minutes (to deactivate the DNA polymerase) before
being stored at 4C. 20 μl aliquots were then used in
qPCR as described above (biological duplicates of each
assay condition gave identical results).
Quantitation of S. aureus DNA and human genomic DNA
in aspirate samples
Total nucleic acids were isolated from two discrete sam-
ples of elbow aspirate fluid as per Stoodley et al. [14].
This material was then used as substrate for direct quan-
titation of S. aureus DNA by real-time PCR with the
proS and lysS assays described above and in Table 1. The
quantity of human genomic DNA contained was deter-
mined by quantitative PCR for human GAPDH using
Gene Expression Assays from Applied Biosystems (Foster
City, CA); assay numbers are Hs02786624-g1 and
Hs03929097-g1.
Assay for S. aureus DNA in samples of mixed human and
bacterial DNA
0.01 ng of purified S. aureus DNA was mixed with
increasing amounts (0 ng to 100 ng) of purified human
genomic DNA. These mixes underwent MDA using the
GenomiPhi V2 DNA Amplification kit (GE Healthcare,
cat. # 25-6600-30) as per the manufacturer’s instruc-
tions. Briefly, mixes containing 0.01 ng of S. aureus
DNA with varying quantities of human DNA were
brought to 10 μl in Sample Buffer, then heat denatured
at 95C × 3 min, then placed on ice. 10 μl of Master Mix
(including reaction buffer and enzyme) were added to
each sample and allowed to incubate at 30C × 1.5 hrs.
The enzyme was then inactivated at 65C × 10 min, then
cooled to 4C. Control reactions lacking only the Geno-
miPhi enzyme were also run. 1 μl of the final reaction
products were then diluted 1:100 in TE, and these
diluted products were then used in qPCR assays for
S. aureus with the lysS and proS loci as described above.
Results
We first established a qPCR assay for S. aureus based on
the single copy loci lysS and proS. qPCR of both target
genes yielded amplimers of the expected molecular
weight on gel electrophoresis (data not shown) and
showed a direct correlation between critical cycle
threshold and substrate concentration. Appropriate sig-
moidal curves for amplimer accumulation were observed
in all instances.
We next determined what degree of amplification might
be afforded by MDA on the naked DNA template used to
validate our S. aureus-specific assays. Pre-incubation with
the GenomiPhi enzyme resulted in a vast increase in the
amount of target S. aureus DNA present, reducing the
threshold critical cycle from ~31.7 to ~16.9. This repre-
sents a theoretical amplification (assuming a two-fold
exponential increase with each cycle reduced, and allowing
for the 20-fold dilution introduced for experimental pur-
poses) of > 214 × 20, or over 300 thousand-fold (Table 2).
We next examined what effect MDA pre-treatment
would have on clinical samples of joint aspirates recov-
ered from a well-characterized infected patient after
total elbow arthroplasty; both samples stored in RNAla-
ter and also snap-frozen directly were tested. In order to
make available DNA for amplification without need for
extensive specimen handling, a simple protocol for
alkali/heat lysis was introduced. Results are shown in
Table 3.
When aspirate samples were unlysed there was no sig-
nal accumulation above the detection threshold, consis-
tent with the presence of inhibitors since these same
materials have yielded PCR amplimers successfully after
purification of nucleic acids within. Aspirate stored in
RNA later as well as stored directly, when lysed, did
give a positive signal on direct qPCR assay but only
when 0.1 μl of material was used, not when greater
quantities of starting material were present, again con-
sistent with the presence of inhibitors. In contrast, all
lysed aspirates subjected to MDA gave convincingly
positive qPCR signals for both proS and lysS, demon-
strating that pre-amplification with MDA expands the
window of detectability in these joint aspirate samples
by at least 100-fold (from 0.1 μl to 10 μl inclusive). Use
of RNAlater as a storage medium had no effect on the
initial detection or ultimate amplification yield.
We next used real-time PCR to quantify the amount
of S. aureus and human genomic DNA present in
Table 2 Quantitation of S. aureus genomic DNA (gDNA)
by real time PCR
MDA S. aur gDNA Probe Average Ct SEM (±)
N 100 ng proS 17.8 0.03
N 10 ng proS 22.1 0.05
N 1 ng proS 24.6 0.03
N 0.1 ng proS 27.7 0.06
N 0.01 ng proS 31.7 0.26
N 0 ng proS U U
(N) 0.01 ng proS 35.4 0.85
(Y) 0.01 ng proS 16.9 0.05
Triplicate samples of isolated S. aureus genomic DNA were assayed by qPCR;
the calculated average threshold critical cycle (Ct) values are provided, as is
the standard error. Each sample concentration gave a highly reproducible
result; the data shown are using the proS probe, but equivalent results were
obtained using lysS. Pre-treatment of S. aureus gDNA by MDA resulted in a
massive reduction in Ct, indicating a massive amplification of template. In
MDA control lacking the DNA polyermase, Ct actually slightly increased, due
to dilution of the starting material. 0 ng of gDNA (negative control) gave no
detectable signal (Ct undetermined, represented as “U” above).
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synovial fluid samples. Assaying two independently
obtained samples from the same patient, we found that
S. aureus DNA was present at 0.014 μg/ml in one sam-
ple, and at 0.020 μg/ml in the other. Human genomic
DNA was present in over a thousand-fold excess by
comparison, measured at 33.6 μg/ml and 79.4 μg/ml
respectively.
In order to verify that MDA could function to amplify
minor quantities of bacterial DNA in the presence of
large (but physiologically relevant) quantities of human
DNA, we next mixed small quantities of purified S. aur-
eus DNA (in roughly the quantity we would expect to
find in a small volume of synovial fluid) with increasing
amounts of purified human genomic DNA. Samples
were either treated +/- MDA; the resulting mixes were
diluted and then assayed by quantitative PCR. Results
are shown in Table 4.
Using 0.01 ng of S. aureus DNA as a starting template,
we were unable to detect any accumulation signal in our
real-time assay under any condition when pre-treatment
with MDA had not been applied. In contrast, when pre-
treatment with MDA was effected, all samples gave con-
vincing positive results, despite the additional dilution.
Results were uniformly positive when up to 10 ng of
human DNA were in the initial mix, representing a thou-
sand-fold excess. Results were still mostly positive, in 10
out of 12 trials, when 100 ng of human DNA were in the
initial template mix, raising the possibility that a > 104-
fold excess of human DNA may itself begin to exert
some inhibitory effect on the ability of MDA to amplify
minor bacterial components in the mix. However, in
general these results support our direct evidence from
the clinical samples that MDA has the potential to be a
useful adjunct to PCR examination of synovial aspirates
with its ability to amplify small quantities of bacterial
DNA in complex mixes.
Discussion
The technique of multiple displacement amplification
relies on the unique properties of the Phi29 DNA poly-
merase, which generates copies of its template DNA
with great fidelity; the calculated error rate of the Phi29
polymerase is 3 × 10-6, almost two orders of magnitude
superior to that of Taq polymerase. The Phi29 catalyzed
reaction proceeds isothermally through a mechanism of
strand displacement, and the enzyme is highly proces-
sive, typically incorporating > 70,000 bp per binding
event [15]. These features, markedly different from
those of PCR-based amplification, make MDA a poten-
tially useful adjunct to quantitative PCR assays without
being subject to the same technical pitfalls as PCR.
MDA has been used for a variety of purposes from a
number of sample types. MDA improved sensitivity of
PCR detection of rare Wolbachia cells in mites by 102-
107-fold [16]. Genomic DNA was amplified by MDA
from lepromatous human tissue, improving the success
of microsatellite analysis of Mycobacterium leprae from
20% to 92% for these highly degraded archived samples
[17]. It has been successfully used to amplify whole gen-
ome DNA from a wide variety of clinical specimens [11]
and from very limited numbers of cells or even single
cells [18-20].
This report represents (to our knowledge) the first
application of MDA to diagnostic challenges within the
orthopedic realm. Although our study focused on
S. aureus, MDA will amplify all DNAs in a complex mix-
ture in a relatively unbiased manner and, thus, should
prove equally useful for detection of other pathogens or
poly-microbial infections. MDA will not distinguish
Table 3 qPCR assay of aspirated synovial fluid, +/- lysis
and MDA
Sample vol. Probe Lysis -, MDA - Lysis +, MDA - Lysis +, MDA +
0.1 μl proS U + +
1.0 μl proS U U +
10 μl proS U U +
0.1 μl proS U + +
1.0 μl proS U U +
10 μl proS U U +
0.1 μl lysS U + +
1.0 μl lysS U U +
10 μl lysS U U +
0.1 μl lysS U + +
1.0 μl lysS U U +
10 μl lysS U U +
Varying volumes of joint aspirate were treated as per the conditions listed
atop each column, either with or without lysis and MDA. “U” indicates that no
critical cycle value was obtained (undetermined), and thus that no template
DNA was detected. “+” indicates that a valid Ct value was obtained, and an
appropriate sigmoidal accumulation curve, indicating successful detection of
template. Results were identical in two samples of aspirate, using the proS
and lysS probes.
Table 4 qPCR assay of purified S. aureus and human DNA
(hDNA) mix, with and without MDA pre-treatment
Sample Probe MDA - MDA +
0.01 ng S. aur + 100 ng hDNA proS U +* (10/12)
0.01 ng S. aur + 10 ng hDNA proS U + (12/12)
0.01 ng S. aur + 1 ng hDNA proS U + (12/12)
0.01 ng S. aur + 0 ng hDNA proS U + (12/12)
Ct values were undetermined (U) for S. aureus DNA without MDA pre-
treatment. In contrast, “+” indicates the successful detection of target template,
demonstrating that MDA had successfully increased the S. aureus component
to the level of detection; the numbers at right in parentheses represent the
number of successful amplification attempts/number of total attempts. When
100 ng of human genomic DNA were used, in 2 out of 12 attempts no signal
detection was observed although results were positive for the majority of trials,
thus prompting a “+*” notation, with the possibility that this amount of excess
background DNA may become partly inhibitory to the MDA.
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between DNA from lysed cells versus DNA from intact
microorganisms, thus, positive results are not necessarily
indicative of bacterial viability, but in the setting of (puta-
tively sterile) synovial fluid any evidence of bacterial
DNA may be regarded as abnormal.
The protocol we describe requires only a brief lysis
step, obviating the need for any subsequent lengthy
nucleic acid purification, and MDA itself demands no
specialized equipment or complicated handling. Poten-
tially, the processing required for assay of clinical syno-
vial fluid/aspirates might be minimized even further,
although a more expanded and detailed study will be
needed to confirm this, as well as to test MDA in a larger
number of samples. Although our initial MDA protocol
required a 16 hour incubation, a newer commercially
available MDA kit (GE Healthcare) requires only 1.5 -
2 hours, possibly bringing even closer the goal of a
simple, speedy and reliable PCR-based molecular assay
for orthopedic joint infections.
Conclusion
MDA is a promising technique that may serve to signifi-
cantly enhance the sensitivity of molecular assays in
cases of suspected joint infection while simultaneously
reducing the specimen handling required.
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